NASDAQ:APRE | Income Statement | Aprea Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$4.03M-$4.03M$0.00-$3.59M-$0.07-$0.0753,483,50453,483,504
2026-03-31$3.43M-$3.43M$0.00-$3.29M-$0.22-$0.2214,685,44814,685,448
2025-12-31$2.65M-$2.64M$0.00-$2.46M-$0.28-$0.28387,289387,289
2025-09-30$3.12M-$3.12M$0.00-$2.97M-$0.47-$0.476,372,9386,372,938
2025-06-30$3.51M-$3.39M$0.00-$3.24M-$0.53-$0.536,083,3296,083,329
2025-03-31$4.25M-$4.09M$0.00-$3.93M-$0.66-$0.665,993,8665,993,866
2024-12-31$3.43M-$3.23M$0.00-$2.89M-$0.47-$0.47149,342149,342
2024-09-30$4.45M-$4.1M$0.00-$3.78M-$0.64-$0.645,939,7555,939,755
2024-06-30$4.41M-$3.85M$0.00-$3.47M-$0.58-$0.585,937,2915,937,291
2024-03-31$3.53M-$3.15M$0.00-$2.81M-$0.67-$0.674,198,3264,198,326
2023-12-31$3.69M-$3.67M$0.00-$3.44M-$0.92-$0.9240,12540,125
2023-09-30$3.84M-$3.52M$0.00-$3.2M-$0.86-$0.863,735,1763,735,176
2023-06-30$3.9M-$3.65M$0.00-$3.26M-$0.87-$0.873,731,5713,731,571
2023-03-31$4.62M-$4.62M$0.00-$4.38M-$1.34-$1.343,260,4843,260,484
2022-12-31$2.65M-$2.65M$0.00-$2.44M$15.34$15.34334,403334,403
2022-09-30$4.2M-$4.2M$0.00-$4.02M-$2.32-$2.321,732,7831,732,783
2022-06-30$98.47M-$98.47M$0.00-$98.26M-$86.72-$86.721,133,0921,133,092
2022-03-31$4.09M$8.07M$0.00-$7.94M-$7.25-$7.251,095,0761,095,076
2021-12-31$4.46M$7.83M$0.00-$7.76M-$33.49-$33.49-20,137,585-20,137,585
2021-09-30$6.02M$9.43M$0.00-$9.45M-$0.45-$0.4521,231,58421,231,584
2021-06-30$6.65M$10M$0.00-$10.25M-$0.48-$0.4821,186,82721,186,827
2021-03-31$6.76M$10.19M$0.00-$9.67M-$0.46-$0.4621,186,82721,186,827
2020-12-31$9.33M$14.22M$0.00-$15.39M-$48.81-$48.81-20,059,116-20,059,116
2020-09-30$8.76M$12.23M$0.00-$12.32M-$0.58-$0.5821,186,82721,186,827
2020-06-30$10.69M$14.48M$0.00-$16.37M21,107,056
2020-03-31$9.1M$11.87M$0.00-$9.4M21,052,726
2019-12-31$8.04M$11.98M$0.00-$13.07M4,824,280
2019-09-30$4.91M$7.22M$0.00-$6.25M1,181,726
2019-06-30$4.32M$5.94M$0.00-$5.26M1,181,583
2019-03-31$3.68M$4.41M$0.00-$3.48M1,171,193
2018-12-31$4.39M$4.9M-$4.68M104
2018-09-30$2.31M$2.93M-$3.14M1,154,573

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$13.52M-$13.23M$0.00-$12.6M-$1.93-$1.936,538,7226,538,722
2024-12-31$15.82M-$14.32M$0.00-$12.96M-$2.35-$2.355,509,9215,509,921
2023-12-31$16.06M-$15.47M$0.00-$14.29M-$3.95-$3.953,617,6073,617,607
2022-12-31$113.39M-$113.39M$0.00-$112.66M-$67.99-$67.991,657,0551,657,055
2021-12-31$23.9M$37.45M-$37.45M$0.00-$37.13M-$34.88-$34.881,064,3251,064,325
2020-12-31$37.88M$52.81M$0.00-$53.48M-$50.61-$50.611,056,6811,056,681
2019-12-31$20.95M$29.54M$0.00-$28.06M-$4.67-$4.676,002,4866,002,486
2018-12-31$14.19M$16.49M$0.00-$15.53M1,154,368
2017-12-31$13.39M$15.85M$0.00-$15.19M1,153,069